In order to characterize the expression pattern of FASN in children with ALL, quantitative reverse transcriptase polymerase chain reaction was used to determine the expression levels of this gene in the bone marrow mononuclear cell samples of 40 children with newly diagnosed ALL and 22 non-cancer control cases. This evidence concerns the gene FASN and acute lymphoblastic leukemia.